Immune Globulin
J9 · Effective Oct 1, 2015
41 active Medicare policies list G04.81, and 3 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J9 · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J15 · Effective Apr 17, 2022
JE · Effective Apr 17, 2022
3 policies from 2 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of G04.81 |
|---|---|---|
| Bortezomib Products | Feb 2, 2024 | Covered |
| Electroconvulsive Therapy | Sep 21, 2023 | Covered |
| Policy | Effective | Status of G04.81 |
|---|---|---|
| Therapeutic Apheresis | Apr 15, 2026 | Covered |
JF · Effective Apr 17, 2022
JJ · Effective Apr 17, 2022
JM · Effective Apr 17, 2022
J5 · Effective Apr 17, 2022
J8 · Effective Apr 17, 2022
JE · Effective Oct 8, 2018
JF · Effective Oct 8, 2018
J15 · Effective Aug 8, 2021
J6 · Effective Nov 1, 2022
JK · Effective Nov 1, 2022
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JL · Effective Jul 1, 2026
J9 · Effective Jul 1, 2026
J5 · Effective Jul 1, 2026
National · Effective Jul 1, 2026
National · Effective Aug 6, 2026
National · Effective Aug 6, 2026
National · Effective May 14, 2026
J5 · Effective Aug 6, 2026
National · Effective Oct 1, 2026
National · Effective Sep 3, 2026
J6 · Effective Apr 1, 2026
National · Effective Oct 1, 2025
National · Effective Nov 1, 2024
J6 · Effective Apr 1, 2026
National · Effective Nov 6, 2025